Davis Behavioral Health Inc

Davis Behavioral Health Inc

Services:
Payment/Insurance/Funding Accepted
• Federal military insurance (e.g., TRICARE)
• SAMHSA funding/block grants
• State-financed health insurance plan other than Medicaid
• Medicare
• Medicaid
• Private health insurance
• Federal, or any government funding for substance use treatment programs
• Cash or self-payment

Language Services

• Spanish
• Sign language services for the deaf and hard of hearing

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Testing

• Drug or alcohol urine screening
• TB screening
• Metabolic syndrome monitoring
• Breathalyzer or blood alcohol testing

Recovery Support Services

• Assistance with obtaining social services
• Housing services
• Mentoring/peer support
• Employment counseling or training
• Recovery coach
• Self-help groups

Special Programs/Groups Offered

• Criminal justice (other than DUI/DWI)/Forensic clients
• Clients who have experienced trauma
• Pregnant/postpartum women
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

License/Certification/Accreditation

• State mental health department
• State Substance use treatment agency
• State department of health

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment
• Outpatient

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Facility Vaping Policy

• Vaping not permitted

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Assessment/Pre-treatment

• Screening for tobacco use
• Screening for mental disorders
• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Screening for substance use

Type of Opioid Treatment

• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Buprenorphine maintenance

Treatment Approaches

• Relapse prevention
• Trauma-related counseling
• Telemedicine/telehealth therapy
• Brief intervention
• Motivational interviewing
• Community reinforcement plus vouchers
• Cognitive behavioral therapy
• Substance use disorder counseling
• Contingency management/motivational incentives

Gender Accepted

• Male
• Female

Transitional Services

• Aftercare/continuing care
• Naloxone and overdose education
• Outcome follow-up after discharge
• Discharge Planning

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity

Ancillary Services

• Suicide prevention services
• Social skills development
• Transportation assistance
• Mental health services
• Case management service

Age Groups Accepted

• Adults
• Young Adults

Education and Counseling Services

• Group counseling
• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
• Family counseling
• Individual counseling

Pharmacotherapies

• Nicotine replacement
• Medication for mental disorders
• Buprenorphine with naloxone
• Acamprosate (Campral®)
• Disulfiram
• Clonidine
• Non-nicotine smoking/tobacco cessation
• Buprenorphine (extended-release, injectable)
• Naltrexone (oral)
• Buprenorphine without naloxone
• Naltrexone (extended-release, injectable)

Facility Smoking Policy

• Smoking not permitted

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

External Opioid Medications Source

• No formal relationship with prescribing entity